Coronary CT Angiography (CCTA) is the best next diagnostic step for this patient.
In a 70-year-old patient with resolved acute atrial fibrillation after amiodarone, hypotension, and positive troponin without chest pain, CCTA should be performed to rule out obstructive coronary artery disease (CAD), followed by cardiac MRI if CCTA is negative. 1
Diagnostic Reasoning
This clinical scenario represents acute myocardial injury with troponin elevation in the absence of typical ischemic symptoms—a common diagnostic challenge that requires systematic evaluation:
Why CCTA First?
The 2025 SIRM/SIC consensus explicitly recommends that for patients with acute myocardial injury (positive troponin) even without ECG ischemic criteria, ruling out obstructive CAD is the priority, preferably using CCTA 1. This applies directly to your patient despite the absence of chest pain, as troponin elevation demands exclusion of type 1 MI.
The most recent 2025 ACC/AHA/ACEP guidelines reinforce that troponin elevation requires urgent evaluation for obstructive CAD regardless of symptom presentation 2. The absence of chest pain does not exclude acute coronary syndrome—approximately 10-40% of patients with atrial fibrillation may be asymptomatic for ischemia 3.
The Differential Diagnosis
The troponin elevation in this context has a broad differential 4:
Most likely causes given the clinical picture:
- Type 2 MI from demand ischemia (hypotension + rapid AF)
- Type 1 MI (must be excluded first)
- Stress cardiomyopathy (Takotsubo)
- Acute myocarditis
- AF-related myocardial strain 5, 6, 7
The 2019 JACC expert panel emphasizes that troponin elevation with acute AF can result from multiple mechanisms, but obstructive CAD must be excluded before attributing it to other causes 4. Research shows that even mildly elevated troponin in AF patients is associated with a 7% one-year MI rate versus 1% in those without elevation 5.
Sequential Diagnostic Algorithm
Step 1: CCTA (First-line)
- Rules out obstructive CAD with high negative predictive value
- Can identify non-obstructive CAD for prognostic stratification
- Provides "one-stop-shop" evaluation when combined with late contrast enhancement 1
Step 2: If CCTA shows no obstructive CAD → Cardiac MRI
- Perform CMR as soon as possible—diagnostic sensitivity decreases with time after the acute event 1
- CMR identifies: myocarditis, stress cardiomyopathy, MINOCA, or other non-ischemic causes of troponin elevation 1, 8
- The 2021 AHA/ACC chest pain guidelines specifically recommend CMR or echocardiography for high-risk troponin-positive patients with non-obstructive CAD 8
Step 3: If CCTA shows obstructive CAD → Invasive coronary angiography
Critical Clinical Pitfalls
Don't Assume AF Alone Explains the Troponin
While AF with rapid ventricular response can cause troponin elevation through myocardial strain 6, 7, this is a diagnosis of exclusion. The combination of hypotension and AF creates a high-risk scenario for type 2 MI from supply-demand mismatch, but type 1 MI must be ruled out first 4.
Don't Wait for Symptoms
The absence of chest pain is misleading—troponin elevation itself defines myocardial injury and mandates investigation 4, 2. The Fourth Universal Definition of MI requires evidence of myocardial ischemia beyond troponin alone, but you cannot determine this without imaging 4.
Timing Matters for CMR
If you proceed to CMR, perform it urgently (within days, not weeks) as diagnostic sensitivity for acute processes like myocarditis decreases rapidly over time 1.
Consider Amiodarone Toxicity
While rare with short-term IV use, amiodarone can cause acute hepatotoxicity and hypotension 9, 10. Check liver enzymes and monitor for progressive hepatic injury, though this wouldn't explain the troponin elevation 10.
Why Not Other Tests First?
Stress testing: Inappropriate—patient had recent hypotension and has positive troponin, making this high-risk and potentially dangerous 2.
Invasive angiography immediately: Reasonable alternative but CCTA is less invasive, provides excellent negative predictive value, and can guide whether catheterization is needed 1, 2.
Echocardiography alone: Useful for assessing wall motion abnormalities and LV function but cannot definitively rule out obstructive CAD 8.
Serial troponins only: Insufficient—you need anatomic or functional imaging to determine the cause 4, 2.
The evidence strongly supports CCTA as the optimal initial test, followed by CMR if coronary arteries are normal, providing a systematic pathway to diagnosis while prioritizing exclusion of life-threatening obstructive CAD.